Vaccine Blurbs #240: Happy Holidays!

p3

Washington State Department of Health | December 18, 2024


Happy Holidays!

happy holidays

Thank you for all you do to immunize Washington's children. Your enrollment in the Childhood Vaccine Program plays a critical role in the health of Washington and we appreciate all you do to keep Washington kids healthy! We hope you have a happy holiday season.

Reminder: DOH offices will be closed December 25th and January 1st. 


January 9th Training: New Vaccine Coordinator Training Requirements for 2025!

Join us on January 9th at noon for a training focused on the new Vaccine Coordinator Training that will replace the CDC's You Call the Shots (YCTS) in 2025. This training is comparable to the YCTS training content with the addition of Washington State Vaccine Program specifics. It will cover all the important information needed to participate in Washington’s Childhood and Adult Vaccine Programs.

Primary and back-up vaccine coordinators must complete this annual training requirement within the current calendar year, prior to their provider agreement renewal deadline. It is also best practice to have all staff who handle and administer vaccines complete the training as well.

We are working on getting continuing education credits for nurses, medical assistants, and pharmacists/pharmacy techs. Stay tuned for more details.

Register for the Training!


Vaccine Choice Update

Changes to order sets have been delayed due to a new requirement for an e-mail address under the facility information in the IIS. This field is now required, and we cannot make changes without this information. An e-mail has been sent to providers impacted, requesting this information. We apologize for the severe delay this has caused in updating order sets and appreciate your cooperation and patience while we address the new requirement.


Federal Vaccine Documentation Requirements

When documenting publicly-supplied childhood vaccines, Federal law requires providers to document the following information in an electronic health record (EHR), the IIS, or in paper charts:

  • Vaccine type (e.g. Tdap)
  • Date the vaccine was administered
  • Vaccine manufacturer
  • Vaccine Lot number
  • Name and credentials of the person who administered the vaccine
  • Vaccine Information Statement (VIS) publication date
  • Date the VIS was given
  • Address where the vaccine was administered (Typically this is programmed into EHRs and is associated with each facility that’s set up in the IIS).

Additionally, providers are also required to document the patient’s eligibility status for every publicly-supplied vaccine administered.


Identifying AVP & CVP Vaccines in Shipments

If your site is dually enrolled in the Adult and Childhood Vaccine Programs (AVP & CVP), you may receive shipments containing both AVP & CVP vaccine orders. You can use the funding sources listed on the packing slip to identify which vaccines were ordered through each program:

  • AVP vaccines will be listed under 317 Doses (highlighted yellow in the packing slip image below)
  • CVP vaccines will be listed under the VFC, State, and/or CHIP Doses (highlighted blue in the image below)
packing slip

It is important to correctly identify AVP and CVP supplied vaccines, so each stock is properly labelled and separated in your storage units and to ensure vaccines are only administered to patients eligible for each program. If you’re unsure or have any issues determining which vaccines were ordered through AVP or CVP, please email WAChildhoodVaccines@doh.wa.gov or WAAdultVaccines@doh.wa.gov.


FluMist McKesson's Return/Replacement & FluMist Replacement Program for CDC 2024‐2025

McKesson has inadvertently shipped AstraZeneca FluMist (NDC: 66019-0311-10) with a shorter expiration date (Lot #: WF2583; Expiry: 12/16/2024) to several providers. To prevent vaccine loss, there are two options available for replacing these vaccines:

Option 1 - FluMist Mckesson's Return/Replacement

If the entire order of FluMist received has not been used, McKesson will replace the short-dated doses with slightly longer-dated ones (January 2025).

If you would like to proceed with this option, please contact us at WAChildhoodVaccines@DOH.WA.GOV to request a replacement. Be sure to include your PIN and the ORDER number. Additionally, please label the doses with "DO NOT USE." We will reconcile the doses in the Immunization Information System (IIS) and inactivate the LOT.

After McKesson processes the return, we will provide you with a FedEx pick-up date. You do not need to maintain the cold chain; just ensure the vaccines are packed securely to prevent any damage during transit.

Once the replacement has been delivered, please manually receive the vaccine in WAIIS.

Option 2 - FluMist Replacement Program for CDC 2024‐2025

If the doses have been partially used, providers can use the 2024-25 FluMist Replacement Program to replace them with doses that are longer dated (March 2025). 

The provider must contact the AstraZeneca Replacement Program by phone or by email, as detailed in the included instructions. A PDF version is available here.

Eligibility Guidelines: Request must be made between Monday, December 2, 2024, and Friday, January 31, 2025, by 7:00 pm CST (5:00 pm PST)  

  • Doses must have been purchased on the CDC contract. Private doses are not eligible for the FluMist® Trivalent Replacement Program for CDC.
  • Product expiration date must be on or before February 2, 2025.
  • AstraZeneca will replace expired doses of FluMist® while supplies last.

Important Notes:

  • Follow all instructions provided by McKesson Specialty Health (MSH).
  • Pack the expired/expiring doses as instructed. Expired doses of FluMist do not have to be returned cold.
  • McKesson will email a FEDEX label to you to ship back the expired doses.
  • Doses can only be replaced in increments of 10. The minimum number of doses that can be replaced is 10 doses. Multiple eligible lot #'s can be used to achieve multiple of 10.
  • MSH validates the vaccine received against request.
  • If the doses received match the request, doses would ship within 72 business hours.
  • If the doses received exceed the request, only the doses requested will be shipped.
  • If doses received are less than requested, only those received (rounded down to the nearest multiple of 10) will be replaced.
  • Requests for expiring doses cannot be made more than 14 days before the sprayer's expiration date.
  • All doses requested for replacement must be received by Saturday, February 15, 2025. Once qualifying doses are received, replacement products will be shipped.
  • Any doses received after February 15 will not be replaced.
  • Receive the replacement order manually in WAIIS.

Example: Provider requests 20 doses to be replaced

  • McKesson receives 20 doses, 20 doses will ship for replacement.
  • McKesson receives 30 doses, 20 doses will ship for replacement.
  • McKesson receives 18 doses, 10 doses will ship for replacement.

For questions about this program, please contact the FluMist® Replacement Program for CDC at 1-877-633-7375 or flumistreplacement@mckesson.com.

IIS reconciliation: To reconcile the lot numbers being replaced through the FluMist Replacements Program in the Washington Immunization Information System (WAIIS), follow these steps:

  • Choose the Category "Correction" and the Reason "Correction of invalid entry"
  • Once the Lot # gets down to zero in your reconciliation page, please inactivate the LOT.

If you do not have the option to use this Category/Reason, please contact your clinic's IIS system administrator or waiishelpdesk@doh.wa.gov. Please note that this category and reason should only be used in exceptional circumstances, such as this one.

Clinical Corner

CDC’s Pink Book Training: The Epidemiology & Prevention of Vaccine Preventable Diseases course is coming to Washington state!

We are excited to announce that the CDC’s Pink Book Training: The Epidemiology & Prevention of Vaccine Preventable Diseases course is coming to Washington state!

Please Save the Date for this exciting in-person event:

When: June 2-4, 2025

Where: Tacoma, WA

This event is hosted by WithinReach in partnership with the Washington State Department of Health. Registration and conference details are coming soon to immunitycommunitywa.org, but we encourage you to mark your calendars until then.


OPV Dose Correction

WA DOH (Department of Health) has discovered that doses of oral poliovirus vaccine (OPV) in the WA Immunization Information System (WAIIS) on or after 04/01/2016 have been incorrectly entered as trivalent OPV (tOPV)). In April 2016, all OPV-using countries simultaneously switched routine polio vaccination from tOPV to bivalent OPV (bOPV), which contains vaccine for only types 1 and 3 polioviruses. Monovalent OPV (mOPV) is also used during an outbreak response. As a result, the CDC recommended immunization schedule says doses of OPV administered on or after 04/01/2016 should not be counted. For the polio series to be evaluated correctly in the WAIIS, OPV doses on or after 04/01/2016 should be documented as bOPV or OPV-unspecified so they are not counted as valid in the series completion.

In mid-December of 2024, WA DOH will begin changing doses incorrectly documented as tOPV to OPV-unspecified to ensure that the doses are correctly evaluated by the WAIIS forecaster. This could result in new patients being forecasted as needing additional polio vaccine. Clinics can run a coverage rate report after the change to know what patients they own were affected and need to be contacted for vaccination. We will also send an email to organizations that are affected with additional information. Please vaccinate these patients with additional doses of IPV according to the Immunization Schedules | Vaccines & Immunizations | CDC. Additionally, please ensure that your facility is correctly documenting OPV doses on or after 04/01/2016 as bOPV or OPV-unspecified. Only OPV doses before this date should be documented as tOPV.

For more information, please see this Quick Reference Guide Polio Vaccine Documentation In The WAIIS. Questions about this change can be directed to ImmuneNurses@doh.wa.gov.  


Updated Bexsero Interval Between Doses

In August 2024, FDA revised the licensed schedule for Bexsero to be the same as the schedule and dosing interval for Trumenba. The change was made due to an improvement shown in the immune response to Bexsero when 2 doses were given 6 months apart instead of 1 month apart. No additional doses are recommended for people who completed the 2 doses of Bexsero using a 1-month interval before October 24, 2024. Patients who received Bexsero or Trumenba where dose 2 was given less than 6 months after dose 1 on or after October 25, 2024 should receive a third dose at least 4 months after dose 2. The WAIIS forecast currently shows dose 2 is recommended 4 weeks after dose 1 and accepts dose 2 given 6 months after dose 1. We are working with our vendor to update the forecast.

Reference:

New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, October 2024 | MMWR


NFID Clinical Vaccinology Course Available as a Recording

The National Foundation for Infectious Diseases (NFID) sponsored a very informative and useful Clinical Vaccinology Course in November and the recordings are now available for a fee until 1/31/25. Register now to gain access to tools and strategies that will help you to learn more about current vaccine recommendations and ways to improve vaccination rates. Here are the sessions available:

  • Protecting Children and Adolescents: The Importance of Immunization
  • Preventing Pneumococcal Disease through Vaccination
  • Adult Vaccination
  • Managing Outbreaks through Vaccination
  • Travel Vaccines: Know Before You Go
  • Improving Vaccine Confidence

Clarification About Nirsevimab Administration for Babies Born Outside of RSV Season

We have received questions about administration of nirsevimab for babies born outside of the respiratory season. Here’s more information and references to guide nirsevimab administration for these babies.

CDC currently recommends Abrysvo vaccine for pregnant people at 32 0/7 weeks’ through 36 6/7 weeks’ gestation between September through January. Vaccinating a pregnant person in February or March for an infant born in April or May will provide that infant limited protection during the RSV season since protection from maternal vaccination wanes over time.

Instead of giving Abrysvo to pregnant people whose babies will be born after the RSV season, providers are recommended to administer nirsevimab ideally in October for a baby born from April-September OR at birth if the baby is born between October-March. Administer nirsevimab only if the baby didn’t previously get nirsevimab and the pregnant person wasn’t administered Abrysvo. The infant would be better protected by receiving nirsevimab just before or at the start of the RSV season.

References:


Pertussis Updates and Current Vaccine Recommendations Webinars Recording Available with CEs

Registration for the Pertussis Updates Webinar held on December 5, 2024 was full, but those who are interested can view the recording that is now available on our web page. The Current Vaccine Recommendations & Preventing Vaccine Administration Errors recording is also available and continuing education credit is available for nurses, medical assistants, and pharmacists/pharmacy techs who watch the recording of DOH webinars.


For questions about the immunization schedule, the Immunization Information System forecast, or any other immunization clinical questions, please send an email to ImmuneNurses@doh.wa.gov. Check out the Immunization Training web page for more resources and training opportunities.


Helpful Hints

With the holidays quickly approaching, please be mindful of shipping delays and limited or no shipping days.  Orders placed after December 10th will be shipped and delivered in January. Please note that there will be no vaccine deliveries made during the week of Christmas and New Year's. You can place an order off your typical schedule if needed. Please ensure your accountability reports are up to date prior to placing orders to ensure expedited processing. It's also a good idea to update your shipping hours in your provider agreement if needed. Check out the holiday shipping calendar on our website for more information